Soleno Therapeutics, Inc. ( SLNO) - Stock Earnings
Stock symbol SLNO is outdated, potentially delisted? Maybe it is available on other exchange?
SLNO Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q3 | 26.0 million USD | 66.0 million USD |
| 2025Q4 | 43.4 million USD | 91.7 million USD |
| 2026Q1 | 31.4 million USD | 94.6 million USD |
| 2026Q2 Est. | — | — |
| 2026Q3 Est. | — | — |
| 2026Q4 Est. | — | — |
SLNO Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2023 | -39.0 million USD | — USD |
| 2024 | -175.9 million USD | — USD |
| 2025 | 20.9 million USD | 190.4 million USD |
| 2026 Est. | — | — |
SLNO
Price: $53.01
52 week price:
Earnings Per Share: 1.93 USD
P/E Ratio: 27.47
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 110100
Ebitda: -13.8 millionMarket Capitalization: 2.8 billion